These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37661733)

  • 1. Introducing of novel class of pyrano[2,3-
    Almaghrabi M; Musa A; Aljohani AKB; Ahmed HEA; Alsulaimany M; Miski SF; Mostafa EM; Hussein S; Parambi DGT; Ghoneim MM; Elgammal WE; Halawa AH; Hammad A; El-Agrody AM
    J Biomol Struct Dyn; 2024 Nov; 42(18):9529-9546. PubMed ID: 37661733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
    Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies.
    Saleh MA; Elmaaty AA; El Saeed HS; Saleh MM; Salah M; Ezz Eldin RR
    Bioorg Chem; 2022 Dec; 129():106186. PubMed ID: 36215786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
    Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
    Alagumuthu M; Arumugam S
    Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: Synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity.
    Omar MA; Masaret GS; Abbas EMH; Abdel-Aziz MM; Harras MF; Farghaly TA
    Bioorg Chem; 2020 Nov; 104():104316. PubMed ID: 33022549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase.
    Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH
    Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WQ-3810, a fluoroquinolone with difluoropyridine derivative as the R1 group exerts high potency against quinolone-resistant
    Koide K; Kim H; Whelan MVX; Belotindos LP; Tanomsridachchai W; Changkwanyeun R; Usui M; Ó Cróinín T; Thapa J; Nakajima C; Suzuki Y
    Microbiol Spectr; 2024 Oct; 12(10):e0432223. PubMed ID: 39162520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1,2,4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors.
    Mohamed NG; Sheha MM; Hassan HY; Abdel-Hafez LJM; Omar FA
    Bioorg Chem; 2018 Dec; 81():599-611. PubMed ID: 30248511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors.
    Mohammed HHH; Ali DME; Badr M; Habib AGK; Mahmoud AM; Farhan SM; Gany SSHAE; Mohamad SA; Hayallah AM; Abbas SH; Abuo-Rahma GEA
    Mol Divers; 2023 Aug; 27(4):1751-1765. PubMed ID: 36152132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, molecular modeling, and antimicrobial potential of novel 3-[(1H-pyrazol-3-yl)imino]indolin-2-one derivatives as DNA gyrase inhibitors.
    Alzahrani AY; Ammar YA; Salem MA; Abu-Elghait M; Ragab A
    Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100266. PubMed ID: 34747519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and radiosterilization of new hydrazono-quinoline hybrids as DNA gyrase and topoisomerase IV inhibitors: Antimicrobial and hemolytic activities against uropathogenic isolates with molecular docking study.
    Ammar YA; Micky JA; Aboul-Magd DS; Abd El-Hafez SMA; Hessein SA; Ali AM; Ragab A
    Chem Biol Drug Des; 2023 Feb; 101(2):245-270. PubMed ID: 36305722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel Triazole-Containing Pyrazole Ester Derivatives as Potential Antibacterial Agents.
    Chu MJ; Wang W; Ren ZL; Liu H; Cheng X; Mo K; Wang L; Tang F; Lv XH
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of some novel hybrid molecules based on 4-thiazolidinone bearing pyridine-pyrazole scaffolds: molecular docking and molecular dynamics simulations of its major constituent onto DNA gyrase inhibition.
    Desai NC; Jadeja DJ; Jethawa AM; Ahmad I; Patel H; Dave BP
    Mol Divers; 2024 Apr; 28(2):693-709. PubMed ID: 36750538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chrysin based pyrimidine-piperazine hybrids: design, synthesis, in vitro antimicrobial and in silico E. coli topoisomerase II DNA gyrase efficacy.
    Patel KB; Rajani D; Ahmad I; Patel H; Patel HD; Kumari P
    Mol Divers; 2024 Jun; 28(3):1377-1392. PubMed ID: 37318711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking.
    Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S
    Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new exploration toward adamantane derivatives as potential anti-MDR agents: Design, synthesis, antimicrobial, and radiosterilization activity as potential topoisomerase IV and DNA gyrase inhibitors.
    Ragab A; Abusaif MS; Aboul-Magd DS; Wassel MMS; Elhagali GAM; Ammar YA
    Drug Dev Res; 2022 Sep; 83(6):1305-1330. PubMed ID: 35716118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyranopyrazole derivatives comprising a benzoxazole core as antimicrobial inhibitors: Design, synthesis, microbial resistance and machine aided results.
    Reddy GM; Kumari AK; Reddy VH; Garcia JR
    Bioorg Chem; 2020 Jul; 100():103908. PubMed ID: 32413632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives.
    El-Shershaby MH; El-Gamal KM; Bayoumi AH; El-Adl K; Ahmed HEA; Abulkhair HS
    Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000277. PubMed ID: 33078877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antimicrobial evaluation and in silico studies of coumarin derivatives tagged with pyrano-pyridine and pyrano-pyrimidine moieties as DNA gyrase inhibitors.
    Fayed EA; Nosseir ES; Atef A; El-Kalyoubi SA
    Mol Divers; 2022 Feb; 26(1):341-363. PubMed ID: 33895960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.